IP Library › Granted Patent US 9,994,631
Granted Patent B2
US 9,994,631 · App. 14/691,562 · Granted Jun 12, 2018

Signal biomarkers

Inventors: Christopher Joseph Pemberton (Christchurch, NZ); Arthur Mark Richards (Christchurch, NZ)
Assignee: UPSTREAM MEDICAL TECHNOLOGIES LIMITED
C07K16/18C07K7/06C07K7/08C07K16/22C07K16/26G01N33/74G01N33/746C07K2317/24C07K2317/34C07K2317/76G01N2333/505G01N2333/58G01N2800/324G01N2800/325G01N2800/347G01N2800/52
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,994,631
App. No.
14/691,562
Granted
Jun 12, 2018
Kind
B2
Abstract

Diagnostics relating to C-type natriuretic and erythropoietin signal peptides and fragments, and kits, uses and applications therefore.

Claims (25)

1. An antibody, or antigen-binding fragment thereof, which specifically binds a peptide of C-type natriuretic signal peptide CNPsp selected from CNPsp(1-13) peptide having an amino acid sequence consisting of SEQ ID NO:5 or CNPsp(14-23) peptide having an amino acid sequence consisting of SEQ ID No:6,

wherein the antibody, or antigen-binding fragment thereof is immobilized on a solid matrix or is labeled.

2. The antibody, or antigen-binding fragment thereof, of claim 1 , wherein the antibody, or antigen-binding fragment thereof, is a polyclonal, monoclonal, chimeric, or humanized antibody or antigen-binding fragment thereof.

3. The antibody, or antigen-binding fragment thereof, of claim 1 wherein the antibody, or antigen-binding fragment thereof, is labelled with a detectable marker.

4. The antibody, or antigen-binding fragment thereof, of claim 1 , wherein the antibody, or antigen-binding fragment thereof, specifically binds CNPsp(1-13) peptide having an amino acid sequence consisting of SEQ ID NO:5.

5. The antibody, or antigen-binding fragment thereof, of claim 1 , wherein the antibody, or antigen-binding fragment thereof, specifically binds CNPsp(14-23) peptide having an amino acid sequence consisting of SEQ ID NO:6.

6. The antibody, or antigen-binding fragment thereof, of claim 1 , wherein the antibody, or antigen-binding fragment thereof, is in a complex bound to a C-type natriuretic signal peptide (CNPsp) to which the antibody, or antigen-binding fragment thereof, specifically binds.

7. The antibody, or antigen-binding fragment thereof, of claim 1 , wherein the antibody, or antigen-binding fragment thereof, is immobilized on a solid matrix.

8. The antibody, or antigen-binding fragment thereof, of claim 6 , wherein the antibody, or antigen-binding fragment thereof, is immobilized on a solid matrix.

9. A composition comprising:

a first anti-C-type natriuretic signal peptide (CNPsp) antibody, or antigen-binding fragment thereof, immobilized on a solid matrix;

a CNPsp or fragment thereof bound to the first anti-CNPsp antibody, or antigen-binding fragment thereof; and

a second anti-CNPsp antibody, or antigen-binding fragment thereof, bound to the CNPsp or fragment thereof, wherein the second anti-CNPsp antibody, or antigen-binding fragment thereof, binds to a site on CNPsp or fragment thereof that is different from the site bound by the first anti-CNPsp antibody, or antigen-binding fragment thereof, wherein

either the first or the second anti-CNPsp antibody, or antigen-binding fragment thereof, is the anti-CNPsp antibody, or antigen-binding fragment thereof, which specifically binds a peptide of CNPsp selected from CNPsp(1-13) peptide having an amino acid sequence consisting of SEQ ID NO:5 or CNPsp(14-23) peptide having an amino acid sequence consisting of SEQ ID NO:6.

10. The composition of claim 9 , wherein the second anti-CNPsp antibody, or antigen-binding fragment thereof, is labeled.

11. The composition of claim 9 , wherein either the first or the second anti-CNPsp antibody, or antigen-binding fragment thereof, binds the CNPsp(1-13) peptide having an amino acid sequence consisting of SEQ ID NO:5.

12. The composition of claim 9 , wherein either the first or the second anti-CNPsp antibody, or antigen-binding fragment thereof, binds the CNPsp(14-12) peptide having an amino acid sequence consisting of SEQ ID NO:6.

13. A kit comprising:

a first anti-C-type natriuretic signal peptide (CNPsp) antibody, or antigen-binding fragment thereof, immobilized on a solid matrix; and

a second anti-CNPsp antibody, or antigen-binding fragment thereof, wherein the second anti-CNPsp antibody, or antigen-binding fragment thereof, binds to a site on CNPsp or fragment thereof that is different from the site bound by the first anti-CNPsp antibody, wherein

either the first or the second anti-CNPsp antibody, or fragment thereof, is the anti-CNPsp antibody, or antigen-binding fragment thereof, which specifically binds a peptide of CNPsp selected from CNPsp(1-13) peptide having an amino acid sequence consisting of SEQ ID NO:5 or CNPsp(14-23) peptide having an amino acid sequence consisting of SEQ ID NO:6.

14. The kit of claim 13 , wherein the second anti-CNPsp antibody, or antigen-binding fragment thereof, is labeled.

15. The kit of claim 13 , wherein either the first or the second anti-CNPsp antibody, or antigen-binding fragment thereof, binds the CNPsp(1-13) peptide having an amino acid sequence consisting of SEQ ID NO:5.

16. The kit of claim 13 , wherein either the first or the second anti-CNPsp antibody, or antigen-binding fragment thereof, binds the CNPsp(14-23) peptide having an amino acid sequence consisting of SEQ ID NO:6.

17. The kit of claim 13 , wherein the solid matrix is a porous strip or chip.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 4, 2018
From: OTAGO INNOVATION LIMITED
To: UPSTREAM MEDICAL TECHNOLOGIES LIMITED
Reel/Frame 045720/0971 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 27, 2017
From: PEMBERTON, CHRISTOPHER JOSEPH; RICHARDS, ARTHUR MARK
To: OTAGO INNOVATION LIMITED
Reel/Frame 042161/0562 →
Continuity (3)
Division 13186447 · Jul 19, 2011
Provisional Application 61365677 · Jul 19, 2010
Related Publication 20150353632A1 · Dec 10, 2015